Clinical Trials Working Group
The purpose of the Clinical Trials Working Group (CTWG) is to advise the National Cancer Advisory Board and
its Subcommittee on Clinical Investigations on the development, conduct, infrastructure,
and support necessary for the optimal coordination and future progress of the entire
range of intramural and extramural clinical research trials supported by the National
Cancer Institute, including diagnosis, treatment, and prevention studies.
View the Members of the Clinical Trials Working Group
Overview of the Clinical Trials Working Group
View CTWG Meeting Schedule
View presentations about CTWG to NCI advisory boards
Posted 02/08/2006
CTWG Implementation Update to NCAB
Posted 06/07/2005
Final CTWG report to the National Cancer Advisory Board, “Restructuring the National Cancer Clinical Trials Enterprise”
Press Release Announcing Report Acceptance
Posted 05/14/2005
CTWG Presentation at ASCO Annual Meeting
Posted 02/17/2005
Summary of Public Comment to CTWG Open Web Forum
CTWG Draft Recommendations for Public Comment
Posted 02/16/2005
CTWG to Unveil Draft Proposal and Invite Continuing Input at NCAB
|
